Financial News
News releases from Geron Corporation
Geron Corporation Reports Fourth Quarter and Annual 2007 Financial Results and Highlights
February 27, 2008
Tickers
GERN
Geron Ranked in Biotechnology Patent Scorecard Published in The Wall Street Journal
February 13, 2008
Tickers
GERN
Geron Corporation to Present at BIO CEO & Investor Conference
February 07, 2008
Tickers
GERN
Geron's Second U.S. Patent for Production of Pancreatic Islets from Human Embryonic Stem Cells Strengthens Company's Intellectual Property Position
February 04, 2008
Tickers
GERN
Dr. Thomas Okarma Resumes Direct Leadership of Geron's Oncology Drug Development Activities
January 24, 2008
Tickers
GERN
Geron and Sienna Enter Into License Agreement for Cancer Diagnostics
January 23, 2008
Tickers
GERN
Geron Receives Milestone Payment from Merck Triggered by IND Filing for Telomerase Cancer Vaccine Candidate
December 11, 2007
Tickers
GERN
Geron Initiates Clinical Trial of Telomerase Inhibitor Drug in Patients with Multiple Myeloma
November 27, 2007
Tickers
GERN
Tickers
GERN
Recent Advances in Cellular Reprogramming
November 20, 2007
Tickers
GERN
Tickers
GERN
Data Show Geron's Cell-Based Therapeutic for Spinal Cord Injury Survives and Exhibits Remyelination for at Least Nine Months Following Injection
November 06, 2007
Tickers
GERN
Geron Corporation to Present at Rodman & Renshaw Healthcare Conference
November 02, 2007
Tickers
GERN
Tickers
GERN
Tickers
GERN
Geron Corporation to Present at UBS Global Life Sciences Conference
September 24, 2007
Tickers
GERN
Pharmexa Loses European Patent Appeal for Broad Claims to Telomerase-Based Cancer Vaccines
September 04, 2007
Tickers
GERN
Tickers
GERN
Tickers
GERN
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia
July 11, 2007
Tickers
GERN
Tickers
GERN
Geron Corporation to Host Analyst and Investor Meeting in New York City on July 17, 2007
July 05, 2007
Tickers
GERN
Tickers
GERN
Geron Increases Stake in TA Therapeutics Joint Venture
June 18, 2007
Tickers
GERN
Geron Corporation to Present at Needham & Company Biotechnology and Medical Technology Conference
June 12, 2007
Tickers
GERN
Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
June 12, 2007
Tickers
GERN
Tickers
GERN
Tickers
GERN
Tickers
GERN
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.